Vancomycin-lock group (n = 68) | Control group (n = 69) | p value | |
---|---|---|---|
Gender (male, n (%)) | 42 (61.8) | 34 (49.3) | 0.170* |
Gestational age, Wk | 29.8 ± 1.90 | 30.1 ± 2.33 | 0.323 |
Birth weight, Kg | 1.2 ± 0.19 | 1.3 ± 0.23 | 0.765 |
5-min APGAR score | 8.29 ± 1.04 | 8.7 ± 0.71 | 0.010 |
Comorbilities | |||
Neonatal sepsis, n (%) | 43 (63.2) | 42 (60.9) | 0.861* |
NRDS, n (%) | 46 (67.6) | 44 (63.8) | 0.720* |
PDA, n (%) | 30 (44.1) | 31 (44.9) | 1.000* |
IVH, n (%) | 11 (16.2) | 16 (23.2) | 0.391* |
NEC, n (%) | 6 (8.8) | 7 (10.1) | 1.000* |
Meningitis, n (%) | 4 (5.9) | 15 (21.7) | 0.012* |
PROM time, h | 40.2 ± 114 | 45.3 ± 92.9 | 0.776 |
MV time, d | 12.8 ± 13.1 | 17.0 ± 17.9 | 0.115 |
PICC time, d | 33.0 ± 12.7 | 33.7 ± 19.6 | 0.798 |
TPN or PPN time, d | 35.2 ± 15.7 | 33.9 ± 17.8 | 0.660 |
Hospital stay, d | 48.3 ± 16.6 | 51.8 ± 28.2 | 0.376 |
Hospitalization costs, RMB (Yuan) | 110,000 ± 53,000 | 118,000 ± 80,000 | 0.491 |